Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Horizon Pharma

Horizon Pharma reported $2.56B in Debt for its fiscal quarter ending in March of 2023.

Debt Change
Amgen AMGN:US USD 61.6B 22.65B
AstraZeneca AZN:LN USD 31.5B 2.27B
Bausch Health Companies Inc VRX:CN USD 20.65B 113M
Bristol-Myers Squibb BMY:US USD 37.83B 1.49B
Coherus Biosciences CHRS:US USD 471.62M 2.05M
Eli Lilly LLY:US USD 18.88B 2.64B
Endo International ENDP:US USD 7.69B 7.69B
Horizon Pharma HZNP:US USD 2.56B 2.61M
Novartis NOVN:VX USD 29.15B 1.24B
Pacira PCRX:US USD 553.77M 135.7M
Perrigo PRGO:US USD 4.1B 5M
Prestige Brands PBH:US USD 1.35B 79M
Revance Therapeutics RVNC:US USD 398.47M 18.43M
Supernus Pharmaceuticals SUPN:US USD 480.86M 78.9M
Takeda 4502:JP JPY 4.38T 95.44B
Xeris Pharmaceuticals Inc XERS:US USD 187.62M 548K
Zoetis ZTS:US USD 6.56B 1.34B